nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—HTR2B—Sorafenib—liver cancer	0.488	0.606	CbGbCtD
Apomorphine—HTR2C—Sorafenib—liver cancer	0.318	0.394	CbGbCtD
Apomorphine—Rhinorrhoea—Sorafenib—liver cancer	0.00499	0.055	CcSEcCtD
Apomorphine—Cardiac failure congestive—Sorafenib—liver cancer	0.00323	0.0357	CcSEcCtD
Apomorphine—Pain in extremity—Sorafenib—liver cancer	0.00293	0.0323	CcSEcCtD
Apomorphine—Dehydration—Sorafenib—liver cancer	0.00273	0.0301	CcSEcCtD
Apomorphine—Nasopharyngitis—Sorafenib—liver cancer	0.00262	0.0289	CcSEcCtD
Apomorphine—Pneumonia—Sorafenib—liver cancer	0.00227	0.0251	CcSEcCtD
Apomorphine—Flushing—Sorafenib—liver cancer	0.00188	0.0208	CcSEcCtD
Apomorphine—Mental disorder—Sorafenib—liver cancer	0.00178	0.0196	CcSEcCtD
Apomorphine—Dyskinesia—Epirubicin—liver cancer	0.00159	0.0175	CcSEcCtD
Apomorphine—Syncope—Sorafenib—liver cancer	0.00158	0.0175	CcSEcCtD
Apomorphine—Loss of consciousness—Sorafenib—liver cancer	0.00155	0.0171	CcSEcCtD
Apomorphine—Arthralgia—Sorafenib—liver cancer	0.0015	0.0166	CcSEcCtD
Apomorphine—Injection site reaction—Epirubicin—liver cancer	0.00148	0.0164	CcSEcCtD
Apomorphine—Dyskinesia—Doxorubicin—liver cancer	0.00147	0.0162	CcSEcCtD
Apomorphine—Shock—Sorafenib—liver cancer	0.00142	0.0156	CcSEcCtD
Apomorphine—Injection site reaction—Doxorubicin—liver cancer	0.00137	0.0151	CcSEcCtD
Apomorphine—Ecchymosis—Epirubicin—liver cancer	0.00135	0.0149	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00131	0.0145	CcSEcCtD
Apomorphine—Dyspnoea—Sorafenib—liver cancer	0.00128	0.0142	CcSEcCtD
Apomorphine—Ecchymosis—Doxorubicin—liver cancer	0.00125	0.0138	CcSEcCtD
Apomorphine—Fatigue—Sorafenib—liver cancer	0.00124	0.0137	CcSEcCtD
Apomorphine—Constipation—Sorafenib—liver cancer	0.00123	0.0136	CcSEcCtD
Apomorphine—Cardiac failure congestive—Epirubicin—liver cancer	0.00119	0.0132	CcSEcCtD
Apomorphine—Cardiac failure congestive—Doxorubicin—liver cancer	0.00111	0.0122	CcSEcCtD
Apomorphine—Pain in extremity—Epirubicin—liver cancer	0.00108	0.0119	CcSEcCtD
Apomorphine—Asthenia—Sorafenib—liver cancer	0.00103	0.0114	CcSEcCtD
Apomorphine—Pruritus—Sorafenib—liver cancer	0.00102	0.0112	CcSEcCtD
Apomorphine—Dehydration—Epirubicin—liver cancer	0.00101	0.0111	CcSEcCtD
Apomorphine—Pain in extremity—Doxorubicin—liver cancer	0.001	0.0111	CcSEcCtD
Apomorphine—Orthostatic hypotension—Epirubicin—liver cancer	0.00099	0.0109	CcSEcCtD
Apomorphine—Diarrhoea—Sorafenib—liver cancer	0.000986	0.0109	CcSEcCtD
Apomorphine—Nasopharyngitis—Epirubicin—liver cancer	0.000969	0.0107	CcSEcCtD
Apomorphine—Dizziness—Sorafenib—liver cancer	0.000953	0.0105	CcSEcCtD
Apomorphine—Dehydration—Doxorubicin—liver cancer	0.000933	0.0103	CcSEcCtD
Apomorphine—Vomiting—Sorafenib—liver cancer	0.000916	0.0101	CcSEcCtD
Apomorphine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000916	0.0101	CcSEcCtD
Apomorphine—Angina pectoris—Epirubicin—liver cancer	0.000912	0.0101	CcSEcCtD
Apomorphine—Headache—Sorafenib—liver cancer	0.000903	0.00996	CcSEcCtD
Apomorphine—Nasopharyngitis—Doxorubicin—liver cancer	0.000897	0.00989	CcSEcCtD
Apomorphine—Nausea—Sorafenib—liver cancer	0.000856	0.00944	CcSEcCtD
Apomorphine—Angina pectoris—Doxorubicin—liver cancer	0.000844	0.00931	CcSEcCtD
Apomorphine—Pneumonia—Epirubicin—liver cancer	0.00084	0.00926	CcSEcCtD
Apomorphine—Drowsiness—Epirubicin—liver cancer	0.000835	0.00921	CcSEcCtD
Apomorphine—Urinary tract infection—Epirubicin—liver cancer	0.000812	0.00895	CcSEcCtD
Apomorphine—Pneumonia—Doxorubicin—liver cancer	0.000777	0.00857	CcSEcCtD
Apomorphine—Drowsiness—Doxorubicin—liver cancer	0.000773	0.00852	CcSEcCtD
Apomorphine—Urinary tract infection—Doxorubicin—liver cancer	0.000751	0.00828	CcSEcCtD
Apomorphine—Flushing—Epirubicin—liver cancer	0.000696	0.00767	CcSEcCtD
Apomorphine—Mental disorder—Epirubicin—liver cancer	0.000657	0.00724	CcSEcCtD
Apomorphine—Flushing—Doxorubicin—liver cancer	0.000644	0.0071	CcSEcCtD
Apomorphine—Back pain—Epirubicin—liver cancer	0.000631	0.00696	CcSEcCtD
Apomorphine—Mental disorder—Doxorubicin—liver cancer	0.000608	0.0067	CcSEcCtD
Apomorphine—Syncope—Epirubicin—liver cancer	0.000585	0.00645	CcSEcCtD
Apomorphine—Back pain—Doxorubicin—liver cancer	0.000584	0.00644	CcSEcCtD
Apomorphine—Loss of consciousness—Epirubicin—liver cancer	0.000574	0.00632	CcSEcCtD
Apomorphine—Arthralgia—Epirubicin—liver cancer	0.000556	0.00613	CcSEcCtD
Apomorphine—Chest pain—Epirubicin—liver cancer	0.000556	0.00613	CcSEcCtD
Apomorphine—Anxiety—Epirubicin—liver cancer	0.000554	0.00611	CcSEcCtD
Apomorphine—Syncope—Doxorubicin—liver cancer	0.000542	0.00597	CcSEcCtD
Apomorphine—Confusional state—Epirubicin—liver cancer	0.000537	0.00592	CcSEcCtD
Apomorphine—Oedema—Epirubicin—liver cancer	0.000533	0.00587	CcSEcCtD
Apomorphine—Loss of consciousness—Doxorubicin—liver cancer	0.000531	0.00585	CcSEcCtD
Apomorphine—Shock—Epirubicin—liver cancer	0.000524	0.00578	CcSEcCtD
Apomorphine—Hyperhidrosis—Epirubicin—liver cancer	0.000515	0.00568	CcSEcCtD
Apomorphine—Chest pain—Doxorubicin—liver cancer	0.000514	0.00567	CcSEcCtD
Apomorphine—Arthralgia—Doxorubicin—liver cancer	0.000514	0.00567	CcSEcCtD
Apomorphine—Anxiety—Doxorubicin—liver cancer	0.000512	0.00565	CcSEcCtD
Apomorphine—Hypotension—Epirubicin—liver cancer	0.000498	0.00549	CcSEcCtD
Apomorphine—Confusional state—Doxorubicin—liver cancer	0.000497	0.00548	CcSEcCtD
Apomorphine—Oedema—Doxorubicin—liver cancer	0.000493	0.00543	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000485	0.00535	CcSEcCtD
Apomorphine—Shock—Doxorubicin—liver cancer	0.000485	0.00535	CcSEcCtD
Apomorphine—Insomnia—Epirubicin—liver cancer	0.000482	0.00531	CcSEcCtD
Apomorphine—Hyperhidrosis—Doxorubicin—liver cancer	0.000476	0.00525	CcSEcCtD
Apomorphine—Dyspnoea—Epirubicin—liver cancer	0.000475	0.00524	CcSEcCtD
Apomorphine—Somnolence—Epirubicin—liver cancer	0.000474	0.00522	CcSEcCtD
Apomorphine—Hypotension—Doxorubicin—liver cancer	0.000461	0.00508	CcSEcCtD
Apomorphine—Fatigue—Epirubicin—liver cancer	0.000459	0.00506	CcSEcCtD
Apomorphine—Constipation—Epirubicin—liver cancer	0.000455	0.00502	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000449	0.00495	CcSEcCtD
Apomorphine—Insomnia—Doxorubicin—liver cancer	0.000446	0.00491	CcSEcCtD
Apomorphine—Dyspnoea—Doxorubicin—liver cancer	0.000439	0.00484	CcSEcCtD
Apomorphine—Feeling abnormal—Epirubicin—liver cancer	0.000439	0.00484	CcSEcCtD
Apomorphine—Somnolence—Doxorubicin—liver cancer	0.000438	0.00483	CcSEcCtD
Apomorphine—Fatigue—Doxorubicin—liver cancer	0.000425	0.00469	CcSEcCtD
Apomorphine—Constipation—Doxorubicin—liver cancer	0.000421	0.00465	CcSEcCtD
Apomorphine—Feeling abnormal—Doxorubicin—liver cancer	0.000406	0.00448	CcSEcCtD
Apomorphine—Asthenia—Epirubicin—liver cancer	0.000382	0.00421	CcSEcCtD
Apomorphine—Pruritus—Epirubicin—liver cancer	0.000377	0.00416	CcSEcCtD
Apomorphine—Diarrhoea—Epirubicin—liver cancer	0.000364	0.00402	CcSEcCtD
Apomorphine—Asthenia—Doxorubicin—liver cancer	0.000354	0.0039	CcSEcCtD
Apomorphine—Dizziness—Epirubicin—liver cancer	0.000352	0.00388	CcSEcCtD
Apomorphine—Pruritus—Doxorubicin—liver cancer	0.000349	0.00384	CcSEcCtD
Apomorphine—Vomiting—Epirubicin—liver cancer	0.000339	0.00373	CcSEcCtD
Apomorphine—Diarrhoea—Doxorubicin—liver cancer	0.000337	0.00372	CcSEcCtD
Apomorphine—Headache—Epirubicin—liver cancer	0.000334	0.00368	CcSEcCtD
Apomorphine—Dizziness—Doxorubicin—liver cancer	0.000326	0.00359	CcSEcCtD
Apomorphine—Nausea—Epirubicin—liver cancer	0.000316	0.00349	CcSEcCtD
Apomorphine—Vomiting—Doxorubicin—liver cancer	0.000313	0.00346	CcSEcCtD
Apomorphine—Headache—Doxorubicin—liver cancer	0.000309	0.0034	CcSEcCtD
Apomorphine—Nausea—Doxorubicin—liver cancer	0.000293	0.00323	CcSEcCtD
Apomorphine—ADRA2B—Signaling Pathways—JUN—liver cancer	1.35e-05	0.00013	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TGFB1—liver cancer	1.35e-05	0.00013	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—HRAS—liver cancer	1.35e-05	0.00013	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—AKT1—liver cancer	1.35e-05	0.00013	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CASP3—liver cancer	1.34e-05	0.000129	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CTNNB1—liver cancer	1.34e-05	0.000129	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL2—liver cancer	1.34e-05	0.000129	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CASP3—liver cancer	1.33e-05	0.000129	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—liver cancer	1.33e-05	0.000128	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL2—liver cancer	1.33e-05	0.000128	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—HRAS—liver cancer	1.33e-05	0.000128	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—liver cancer	1.33e-05	0.000128	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CDKN1B—liver cancer	1.32e-05	0.000128	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—liver cancer	1.32e-05	0.000128	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—PIK3CA—liver cancer	1.32e-05	0.000127	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CD—liver cancer	1.31e-05	0.000127	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MMP9—liver cancer	1.31e-05	0.000127	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—RAF1—liver cancer	1.31e-05	0.000126	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—STAT3—liver cancer	1.31e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—AKT1—liver cancer	1.31e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CDKN1A—liver cancer	1.31e-05	0.000126	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—liver cancer	1.31e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—liver cancer	1.31e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CCND1—liver cancer	1.31e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	1.3e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—JUN—liver cancer	1.3e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—PIK3CA—liver cancer	1.3e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SERPINE1—liver cancer	1.3e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—PIK3CA—liver cancer	1.3e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CCND1—liver cancer	1.3e-05	0.000125	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CASP3—liver cancer	1.3e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—KRAS—liver cancer	1.3e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—JUN—liver cancer	1.3e-05	0.000125	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL2—liver cancer	1.3e-05	0.000125	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—STAT3—liver cancer	1.29e-05	0.000125	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—STAT3—liver cancer	1.29e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CTNNB1—liver cancer	1.29e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MYC—liver cancer	1.29e-05	0.000124	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—RAF1—liver cancer	1.29e-05	0.000124	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—liver cancer	1.29e-05	0.000124	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	1.29e-05	0.000124	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TGFB1—liver cancer	1.29e-05	0.000124	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—KRAS—liver cancer	1.29e-05	0.000124	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CTNNB1—liver cancer	1.29e-05	0.000124	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MTOR—liver cancer	1.28e-05	0.000123	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CB—liver cancer	1.28e-05	0.000123	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CASP3—liver cancer	1.28e-05	0.000123	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MAPK8—liver cancer	1.28e-05	0.000123	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL2—liver cancer	1.28e-05	0.000123	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—AKT1—liver cancer	1.27e-05	0.000123	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—AKT1—liver cancer	1.27e-05	0.000123	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—KRAS—liver cancer	1.27e-05	0.000122	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—liver cancer	1.27e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MMP9—liver cancer	1.27e-05	0.000122	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CCND1—liver cancer	1.26e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CDKN1A—liver cancer	1.26e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MMP9—liver cancer	1.26e-05	0.000122	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—JUN—liver cancer	1.26e-05	0.000122	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CB—liver cancer	1.26e-05	0.000121	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MTOR—liver cancer	1.26e-05	0.000121	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CDKN1A—liver cancer	1.26e-05	0.000121	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CTNNB1—liver cancer	1.25e-05	0.000121	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—KRAS—liver cancer	1.25e-05	0.00012	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCND1—liver cancer	1.24e-05	0.00012	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—JUN—liver cancer	1.24e-05	0.00012	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MAPK8—liver cancer	1.23e-05	0.000119	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	1.23e-05	0.000119	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—AKT1—liver cancer	1.23e-05	0.000118	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MMP9—liver cancer	1.23e-05	0.000118	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MAPK8—liver cancer	1.23e-05	0.000118	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—AKT1—liver cancer	1.22e-05	0.000118	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—HRAS—liver cancer	1.22e-05	0.000118	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CDKN1A—liver cancer	1.22e-05	0.000118	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MYC—liver cancer	1.22e-05	0.000117	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TGFB1—liver cancer	1.21e-05	0.000117	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MMP9—liver cancer	1.21e-05	0.000116	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—HRAS—liver cancer	1.2e-05	0.000116	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	1.2e-05	0.000116	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CDKN1B—liver cancer	1.2e-05	0.000116	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MYC—liver cancer	1.2e-05	0.000116	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MYC—liver cancer	1.2e-05	0.000116	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TGFB1—liver cancer	1.2e-05	0.000116	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TGFB1—liver cancer	1.2e-05	0.000116	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—KRAS—liver cancer	1.19e-05	0.000115	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MAPK8—liver cancer	1.19e-05	0.000115	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—PIK3CA—liver cancer	1.19e-05	0.000115	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—AKT1—liver cancer	1.19e-05	0.000115	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—AKT1—liver cancer	1.19e-05	0.000115	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	1.18e-05	0.000114	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CDKN1B—liver cancer	1.18e-05	0.000114	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—liver cancer	1.18e-05	0.000114	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CASP3—liver cancer	1.18e-05	0.000114	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL2—liver cancer	1.18e-05	0.000113	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MAPK8—liver cancer	1.17e-05	0.000113	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—RAF1—liver cancer	1.17e-05	0.000113	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—AKT1—liver cancer	1.17e-05	0.000113	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—liver cancer	1.17e-05	0.000113	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—AKT1—liver cancer	1.17e-05	0.000113	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—STAT3—liver cancer	1.17e-05	0.000113	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—PIK3CA—liver cancer	1.17e-05	0.000112	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CASP3—liver cancer	1.16e-05	0.000112	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL2—liver cancer	1.16e-05	0.000112	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TP53—liver cancer	1.15e-05	0.000111	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—liver cancer	1.15e-05	0.000111	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—PIK3CA—liver cancer	1.15e-05	0.000111	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCND1—liver cancer	1.15e-05	0.00011	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MTOR—liver cancer	1.15e-05	0.00011	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	1.15e-05	0.00011	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—JUN—liver cancer	1.14e-05	0.00011	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—liver cancer	1.14e-05	0.00011	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CTNNB1—liver cancer	1.13e-05	0.000109	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—liver cancer	1.13e-05	0.000109	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TP53—liver cancer	1.13e-05	0.000109	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCND1—liver cancer	1.13e-05	0.000109	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—STAT3—liver cancer	1.13e-05	0.000109	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—JUN—liver cancer	1.13e-05	0.000108	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—KRAS—liver cancer	1.12e-05	0.000108	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—STAT3—liver cancer	1.12e-05	0.000108	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CTNNB1—liver cancer	1.12e-05	0.000108	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MMP9—liver cancer	1.11e-05	0.000107	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TP53—liver cancer	1.11e-05	0.000107	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—KRAS—liver cancer	1.11e-05	0.000107	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—KRAS—liver cancer	1.11e-05	0.000107	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CDKN1A—liver cancer	1.11e-05	0.000107	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—HRAS—liver cancer	1.1e-05	0.000106	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—liver cancer	1.1e-05	0.000106	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—PIK3CA—liver cancer	1.1e-05	0.000106	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MMP9—liver cancer	1.09e-05	0.000106	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—HRAS—liver cancer	1.09e-05	0.000105	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CDKN1A—liver cancer	1.09e-05	0.000105	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—STAT3—liver cancer	1.09e-05	0.000105	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MYC—liver cancer	1.08e-05	0.000105	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—liver cancer	1.08e-05	0.000104	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MAPK8—liver cancer	1.08e-05	0.000104	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TGFB1—liver cancer	1.08e-05	0.000104	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—HRAS—liver cancer	1.08e-05	0.000104	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—AKT1—liver cancer	1.08e-05	0.000104	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	1.08e-05	0.000104	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—STAT3—liver cancer	1.07e-05	0.000103	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MAPK8—liver cancer	1.06e-05	0.000103	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	1.06e-05	0.000103	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—HRAS—liver cancer	1.06e-05	0.000102	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—AKT1—liver cancer	1.06e-05	0.000102	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TP53—liver cancer	1.06e-05	0.000102	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—liver cancer	1.06e-05	0.000102	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CASP3—liver cancer	1.05e-05	0.000102	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL2—liver cancer	1.05e-05	0.000101	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—liver cancer	1.05e-05	0.000101	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MYC—liver cancer	1.05e-05	0.000101	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TGFB1—liver cancer	1.04e-05	0.000101	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MYC—liver cancer	1.04e-05	0.0001	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TGFB1—liver cancer	1.04e-05	0.0001	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PIK3CA—liver cancer	1.03e-05	9.96e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—liver cancer	1.03e-05	9.96e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PIK3CA—liver cancer	1.03e-05	9.92e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCND1—liver cancer	1.03e-05	9.89e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—JUN—liver cancer	1.02e-05	9.87e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PIK3CA—liver cancer	1.02e-05	9.83e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	1.02e-05	9.83e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—liver cancer	1.02e-05	9.8e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	1.02e-05	9.79e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—HRAS—liver cancer	1.01e-05	9.78e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MYC—liver cancer	1.01e-05	9.77e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TGFB1—liver cancer	1.01e-05	9.74e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—KRAS—liver cancer	1e-05	9.66e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TP53—liver cancer	1e-05	9.64e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—liver cancer	9.99e-06	9.63e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MYC—liver cancer	9.97e-06	9.61e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MMP9—liver cancer	9.96e-06	9.6e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TGFB1—liver cancer	9.95e-06	9.59e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	9.92e-06	9.57e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—STAT3—liver cancer	9.89e-06	9.54e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TP53—liver cancer	9.87e-06	9.51e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TP53—liver cancer	9.87e-06	9.51e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—liver cancer	9.83e-06	9.48e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—AKT1—liver cancer	9.73e-06	9.38e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—STAT3—liver cancer	9.73e-06	9.38e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—liver cancer	9.7e-06	9.36e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MAPK8—liver cancer	9.69e-06	9.34e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—KRAS—liver cancer	9.67e-06	9.33e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—AKT1—liver cancer	9.66e-06	9.31e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—KRAS—liver cancer	9.62e-06	9.28e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—HRAS—liver cancer	9.56e-06	9.22e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—AKT1—liver cancer	9.53e-06	9.19e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—HRAS—liver cancer	9.43e-06	9.1e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—HRAS—liver cancer	9.43e-06	9.1e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—AKT1—liver cancer	9.38e-06	9.04e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—KRAS—liver cancer	9.36e-06	9.02e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—KRAS—liver cancer	9.21e-06	8.88e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PIK3CA—liver cancer	9.21e-06	8.88e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MYC—liver cancer	9.19e-06	8.86e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TGFB1—liver cancer	9.17e-06	8.84e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—liver cancer	9.15e-06	8.82e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MYC—liver cancer	9.04e-06	8.72e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—liver cancer	9.03e-06	8.71e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—liver cancer	9.03e-06	8.71e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TGFB1—liver cancer	9.02e-06	8.7e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—AKT1—liver cancer	8.95e-06	8.63e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—liver cancer	8.94e-06	8.62e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TP53—liver cancer	8.91e-06	8.59e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3CA—liver cancer	8.89e-06	8.57e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—STAT3—liver cancer	8.86e-06	8.54e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3CA—liver cancer	8.84e-06	8.52e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3CA—liver cancer	8.6e-06	8.29e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TP53—liver cancer	8.6e-06	8.29e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TP53—liver cancer	8.55e-06	8.25e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—HRAS—liver cancer	8.52e-06	8.21e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—KRAS—liver cancer	8.49e-06	8.19e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	8.46e-06	8.16e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—AKT1—liver cancer	8.44e-06	8.14e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—AKT1—liver cancer	8.4e-06	8.1e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—KRAS—liver cancer	8.36e-06	8.06e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3CA—liver cancer	8.35e-06	8.05e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—AKT1—liver cancer	8.33e-06	8.03e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—AKT1—liver cancer	8.33e-06	8.03e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TP53—liver cancer	8.32e-06	8.02e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MYC—liver cancer	8.23e-06	7.93e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—HRAS—liver cancer	8.22e-06	7.93e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TGFB1—liver cancer	8.21e-06	7.91e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TP53—liver cancer	8.19e-06	7.89e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—HRAS—liver cancer	8.18e-06	7.89e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—liver cancer	8.15e-06	7.86e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—HRAS—liver cancer	7.96e-06	7.67e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—liver cancer	7.87e-06	7.59e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—HRAS—liver cancer	7.83e-06	7.55e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—liver cancer	7.83e-06	7.55e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CA—liver cancer	7.8e-06	7.52e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CA—liver cancer	7.68e-06	7.4e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—liver cancer	7.62e-06	7.34e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KRAS—liver cancer	7.6e-06	7.33e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TP53—liver cancer	7.55e-06	7.28e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—AKT1—liver cancer	7.52e-06	7.25e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—liver cancer	7.49e-06	7.23e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TP53—liver cancer	7.43e-06	7.16e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—AKT1—liver cancer	7.26e-06	7e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—AKT1—liver cancer	7.22e-06	6.96e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—HRAS—liver cancer	7.22e-06	6.96e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—HRAS—liver cancer	7.1e-06	6.85e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—AKT1—liver cancer	7.03e-06	6.77e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	6.99e-06	6.73e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—AKT1—liver cancer	6.91e-06	6.67e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—liver cancer	6.91e-06	6.66e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—AKT1—liver cancer	6.82e-06	6.58e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—liver cancer	6.8e-06	6.55e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TP53—liver cancer	6.76e-06	6.51e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—HRAS—liver cancer	6.46e-06	6.23e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT1—liver cancer	6.37e-06	6.15e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT1—liver cancer	6.27e-06	6.05e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—liver cancer	6.19e-06	5.96e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT1—liver cancer	5.71e-06	5.5e-05	CbGpPWpGaD
